Active, Not Recruiting
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
NCT04030455
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States